ANA SANCHEZ-CAMACHO: Open Payments
NPI 1528472545 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 20 payments from 6 companies in 2025. Trend: 2023 $22 · 2024 $232 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $188 |
| Bausch Health US, LLC | 5 | $115 |
| Janssen Pharmaceuticals, Inc | 3 | $93 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: VRAYLAR, APLENZIN, SPRAVATO, Auvelity, COBENFY, INGREZZA.
Industry payments across CA — which companies pay providers there.
